latest news releases from the newsroom
Interim Report Sectra AB (publ) for the Nine Months Ended January 31, 2003
LINKOPING, Sweden, March 4, 2003 (PRIMEZONE) -- Sectra (Other OTC:SSBBF) (Stockholm:SECTb) reports increased sales and improved earnings for the first nine months of the 2002/2003 fiscal year. Net sales rose 42.1% to SEK 378.3 M (266.3) compared with the corresponding period of the preceding year. Pretax profit increased 30.1% to SEK 51.0 M (39.2), corresponding to a profit margin of 13.5%. Order bookings amounted to SEK 376.4 M (411.1). Earnings per share rose to SEK 1.06 (0.85).
Akzo Nobel: U.S. Food and Drug Administration Grants Arixtra Priority Review for a New Indication
ARNHEM, The Netherlands and PARIS, March 4, 2003 (PRIMEZONE) -- Akzo Nobel's (Nasdaq:AKZOY) human pharmaceutical business unit Organon and Sanofi-Synthelabo announced today that the U.S. Food and Drug Administration (FDA) granted a six-month priority review for a supplemental new drug application (NDA) for Arixtra(R) (fondaparinux sodium) for: "Prophylaxis of deep venous thrombosis, which may lead to pulmonary embolism, in patients undergoing hip fracture surgery, including extended prophylaxis."
Actelion Presents a Full and Promising Clinical Pipeline -- Strong R&D as Basis for Above-industry Growth
ALLSCHWIL/BASEL, Switzerland, March 4, 2003 (PRIMEZONE) -- Actelion Ltd. (SWX:ATLN) (Other OTC:ALIOF) today provided a complete overview of its clinical pipeline at its annual Analyst and Media Day. The company expects that this clinical effort, currently involving four different compounds, could further accelerate the current and continuing growth Actelion realizes through the successful marketing of Tracleer(R) in its first approved indication, pulmonary arterial hypertension (PAH).
Strategic Distribution, Inc.
Strategic Distribution, Inc. Reports 2002 Fourth Quarter and Year End Financial Results
BENSALEM, Pa., March 3, 2003 (PRIMEZONE) -- Strategic Distribution, Inc. (Nasdaq:STRD), a leading provider of maintenance, repair and operating (MRO) supply chain management services, today reported financial results for the fourth quarter and year ended December 31, 2002.